快报
欢迎光临蚂蚁淘在线！ 请登录 免费注册
商品
品牌
文章
热门搜索：
快报
品牌首页 品牌新闻 品牌简介 产品中心 品牌咨询 联系我们
品牌分类
品牌咨询
联系方式
公司地址
苏州工业园区生物纳米园A4#216
联系电话
4000-520-616 / 18915418616
传真号码
0512-67156496
电子邮箱
info@ebiomall.com
公司网址
https://www.ebiomall.com
蚂蚁淘在线 / 品牌中心 / pblassaysci / PBL/Human IFN Beta 1a, mammalian, carrier-free/1 x 106 units/11410-2

PBL/Human IFN Beta 1a, mammalian, carrier-free/1 x 106 units/11410-2

价格
￥11100.00
货号：11410-2
浏览量：127
品牌：pblassaysci
服务
全国联保
正品保证
正规发票
签订合同
商品描述

Human IFN Beta 1a, mammalian, carrier-free

Home / Products / Proteins / Interferons / Human IFN Proteins / Human IFN Beta 1a, mammalian, carrier-free
Product Features:
  • Human IFN Beta 1a, mammalian, recombinant protein expressed in CHO cells
  • Supplied without a carrier protein and as a liquid to maintain higher specific activity
  • Used for MS research studies

Ordering

Catalog No. Pack Size Price Quantity
11410-2

1 x 106 units

$555.00
  • Specifications
  • Citations
  • Documentation

Specifications

FormulationSupplied as a liquid without a carrier protein
Molecular Weight~ 23 kDa
SourcecDNA obtained from human fibroblast interferon beta 1a mRNA expressed in CHO cells
Purity> 95% by SDS-PAGE stained by Coomassie BlueEndotoxin level < 1 EU/μg
BioactivityMeasured using a cytopathic inhibition assay on human lung carcinoma cell line A549 with encephalomyocarditis virus (EMCV). EC50 for IFN beta 1a in this assay is ~1 U/ml
StorageFor retention of full activity store at 2-8°C. Further dilution of this product for long term storage is not recommended.
SynonymsHuman IFNB, Human Beta Interferon, Human IFN Beta 1a, Human Interferon beta 1a, Human Type I Interferon Beta, Human IFN B
Accession NumberV00534 

Citations

20 Citations:

  1. Beug, et al. (2019). The transcription factor SP3 drives TNF-α expression in response to Smac mimetics. Science Signaling, 16 pgs. PMID: 30696705. (link)

  2. Viswanathan, Kasinath, et al. (2017). Quantitative Membrane Proteomics Reveals a Role for Tetraspanin Enriched Microdomains During Entry of Human Cytomegalovirus. PLOS One, 27 pgs. PMID: 29121670. (link)

  3. Rahman, Masmudur, et al. (2017). Myxoma Virus dsRNA Binding Protein M029 Inhibits the Type I IFN-Induced Antiviral State in a Highly Species-Specific Fashion. Viruses, 22 pgs. PMID: 28157174. (link)

  4. Bowen, James, et al. (2017). Zika Virus Antagonizes Type I Interferon Responses During Infection of Human Dendritic Cells. PLOS Pathogens, 30 pgs. PMID: 28152048. (link)

  5. Iyer, Shilpa, et al. (2017). Resistance to Type I Interferons is a Major Determinant of HIV-1 Transmission Fitness. PNAS, 10 pgs. PMID: 28069935. (link)

  6. Schwarz, Toni, et al. (2016). VP24-Karyopherin Alpha Binding Affinities Differ Between Ebolavirus Species Influencing Interferon Inhibition and VP24 Stability. JVI, 44 pgs. PMID: 27974555. (link)

  7. Kativhu, Chido, et al. (2016). A Model to Explain How the Bacille Calmette Guerin (BCG) Vaccine Drives Interleukin-12 Production in Neonates. PLOS One, 12 pgs. PMID: 27571272. (link)

  8. Gao, Xioafei, et al. (2016). Citrobacter rodentium NleB Inhibits Tumor Necrosis Factor (TNF) Receptor-Associated Factor 3 (TRAF3) Ubiquitination to Reduce Host Type I Interferon Production. JBC, 15 pgs. PMID: 27387501. (link)

  9. Rasouli, Javad, et al. (2015). Expression of GM-CSF in T Cells Is Increased in Multiple Sclerosis and Suppressed by IFN-β Therapy. Journal of Immunology, 10 pgs. PMID: 25917097. (link)

  10. Li, Yanfang, et al. (2014). A 20-amino-acid deletion in the neuraminidase stalk and a five-amino-acid deletion in the NS1 protein both contribute to the pathogenicity of H5N1 avian influenza viruses in mallard ducks. PLOS One, 12 pgs. PMID: 24743258. (link)

  11. Mostafa, Heba, et al. (2013). Herpes Simplex Virus 1 ICP22 but Not U_S_1.5 is Required for Efficient Acute Replication in Mice and VICE Domain Formation. JVI, 10 pgs. PMID: 24089574. (link)

  12. Salvi, et al. (2013). Dual regulation of osteopontin production by TLR stimulation in dendritic cells. JLB. PMID: 23610145. (link)

  13. Wang, Bei, et al. (2013). Enterovirus 71 protease 2Apro targets MAVS to inhibit anti-viral type I interferon responses. PLOS Pathogens, 18 pgs. PMID: 23555247. (link)

  14. Patel, Dhara, et al. (2012). High Throughout Screening for Small Molecule Enhancers of the Interferon Signaling Pathway to Drive Next-Generation Antiviral Drug Discovery. PLOS One, 12 pgs. PMID: 22574190. (link)

  15. Popugaeva, Elena, et al. (2012). Dobrava-Belgrade hantavirus from Germany shows receptor usage and innate immunity induction consistent with the pathogenicity of the virus in humans. PLOS One, 10 pgs. PMID: 22545121. (link)

  16. Witte, et al. (2009). Despite IFN-lambda receptor expression, blood immune cells, but not keratinocytes or melanocytes, have an impaired response to type III interferons: implications for therapeutic applications of these cytokines. Nature, 13 pgs. PMID: 19798076. (link)

  17. Aguilar, Patricia, et al. (2008). A Five-Amino-Acid Deletion of the Eastern Equine Encephalitis Virus Capsid Protein Attenuates Replication in Mammalian Systems but Not in Mosquito Cells. JVI, 12 pgs. PMID: 18480443. (link)

  18. Reid, Patrick, et al. (2007). Ebola Virus VP24 Proteins Inhibit the Interaction of NPI-1 Subfamily Karyopherin α Proteins with Activated STAT1. JVI, 9 pgs. PMID: 17928350. (link)

  19. Suzuki, Michitaka, et al. (2007). Endosomal accumulation of Toll-like receptor 4 causes constitutive secretion of cytokines and activation of signal transducers and activators of transcription in Niemann-Pick disease type C (NPC) fibroblasts: a potential basis for glial cell activation in the NPC brain. Journal of Neuroscience, 13 pgs. PMID: 17314284. (link)

  20. LaFleur, David, et al. (2001). Interferon-kappa, a Novel Type I Interferon Expressed in Human Keratinocytes. JBC, 7 pgs. PMID: 11514542. (link)

Documentation

PDF icon 11410-2 Certificate of Analysis (CoA)
PDF icon SDS
PBL分析开发服务可以根据您的特定需求量身定制。分析方法被开发用于研究用途或支持后续GLP验证的标准。 您可以确信，PBL将提供可行的解决方案，从而在开发项目期间最大程度地提高您样本中的数据。我们将与您一起确定必要的步骤，所需的试剂并在潜在问题发生之前确定它们。从原理证明到技术转让，我们的经验将确保我们为您的特定应用需求提供强大而灵敏的测定解决方案。 基于细胞的分析开发 提供但不限于基于细胞的分析开发服务，包括：定制的细胞病变作用，抗增殖和生长促进测定开发报告基因系统或鉴定细胞系以监测目标化合物的活性抗体对生物活性的中和，与鉴定生物活性单克隆抗体（MAb）和监测免疫原性有关免疫分析开发 定制的免疫测定和ELISA支持：药代动力学和药效学研究毒性和免疫原性研究直接，夹心或竞争性ELISA分析开发分析优化服务 特异性和交叉反应性评估分析和动态范围优化减少基质效应（血清，血浆，组织培养基）减少批内和批内变异性标准校准分析稳定性评估协议优化